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ABSTRACT
We describe a new method, which identifies protein
fragments for soluble expression in Escherichia coli
from a randomly fragmented gene library. Inhibition
of E. coli dihydrofolate reductase (DHFR) by tri-
methoprim (TMP) prevents growth, but this can
be relieved by murine DHFR (mDHFR). Bacterial
strains expressing mDHFR fusions with the soluble
proteins green fluroscent protein (GFP) or EphB2
(SAM domain) displayed markedly increased growth
rates with TMP compared to strains expressing
insoluble EphB2 (TK domain) or ketosteroid isomer-
ase (KSI). Therefore, mDHFR is affected by the
solubility of fusion partners and can act as a
reporter of soluble protein expression. Random
fragment libraries of the transcription factor Fli1
were generated by deoxyuridine incorporation and
endonuclease V cleavage. The fragments were
cloned upstream of mDHFR and TMP resistant
clones expressing soluble protein were identified.
These were found to cluster around the DNA binding
ETS domain. A selected Fli1 fragment was expres-
sed independently of mDHFR and was judged to be
correctly folded by various biophysical methods
including NMR. Soluble fragments of the cell-
surface receptor Pecam1 were also identified. This
genetic selection method was shown to generate
expression clones useful for both structural studies
and antibody generation and does not require
a priori knowledge of domain architecture.
INTRODUCTION
Expression of mammalian proteins in Escherichia coli
often results in protein misfolding with protein
degradation and inclusion body formation. This may be
because prokaryotic expression systems lack the necessary
chaperones, natural binding partners and ability to
perform the post-translational modiﬁcations required for
correct folding of a eukaryotic protein. The addition of
solubility enhancing tags can improve expression, but this
is dependent on the properties of the protein target and
precipitation can occur upon tag removal (1,2). A strategy
employed by many laboratories when attempting to
express a large multi-domain protein for structural or
functional studies, including antibody production, is
truncation to produce smaller single domains that are
easier to express in a soluble form in E. coli. This requires
the domains to be annotated onto the linear polypeptide
sequence and primers designed to the domain boundaries
to amplify speciﬁc domains for cloning into expression
vectors. However, the precise domain boundaries can vary
depending on the prediction method used. Although
methods based on sequence alignment are good at
highlighting the core consensus motif, they are less good
at predicting the fold edges because these regions can
contain more sequence variability. For example, the
domains predicted from the Pfam database (3) are often
smaller than the structural domain boundaries. Attempted
expression of a construct based on the Pfam boundaries
would result in premature truncation of N- or C-terminal
a-helixes or b-sheets required to complete the domain
folding unit giving an unstable construct with poor
expression yield. It is possible, in a ‘primer pair walking’
strategy, to design primers spaced at a progressively
greater distances from the core Pfam domain, clone the
PCR products into expression vectors and screen for
soluble expression. However, this approach is laborious,
costly and limited by requiring a mapped protein domain.
A possible solution to this problem is to take a
combinatorial approach by preparing a library of gene
fragments and select those that express well. This requires
eﬃcient methods for gene fragmentation and selection for
soluble protein expression. In this work, we describe both
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a novel genetic selection of soluble protein expression
involving murine dihydrofolate reductase (mDHFR).
Random insert libraries were generated by ﬁrst amplifying
the gene by PCR in the presence of dUTP followed by
cleavage with Endonuclease V in the presence of MnCl2,
which promotes double stranded DNA cleavage at the
second and third phosphodiester bonds 30 of the site of
uracil incorporation (4).
DHFR is an essential enzyme for the survival of E. coli
and converts dihydrofolate into tetrahydrofolate, which
can then be converted to tetrahydrofolate co-factors used
in one-carbon transfer reactions for the de novo synthesis
of purines, thymidylic acid and certain amino acids.
Trimethoprim (TMP) is a potent inhibitor of bacterial
DHFR but not mDHFR, allowing selection for functional
mDHFR by plating the library on minimal expression
plates containing TMP and IPTG for protein induction.
Only transformants expressing functional mDHFR confer
TMP resistance and are able to grow on the selection
plates. mDHFR was previously shown not to perturb the
folding of a set of N-terminal fusion proteins (1), which
together with its monomeric state makes it an ideal
reporter. We show here that expression of functionally
active DHFR is dependent on the folding state of a
variety of upstream control fusion proteins. The selection
process was further validated by producing a library of
the transcription factor Fli1. Screening selected for the
ETS (erythroblast transformation speciﬁc) domain which
was soluble when expressed in isolation (with a hexahis-
tidine tag). This protein was judged to be folded when
15N
labelled and examined by 2D NMR.
A library of random DNA fragments was also
generated of the type 1 integral membrane receptor
Pecam1. Selection identiﬁed a number of extracellular
and intracellular protein expression constructs. A cyto-
plasmic construct was expressed with a hexahistidine tag
and although not folded as judged by 1D and 2D NMR,
this construct was used successfully to produce antibodies
in a phage display selection that gave a speciﬁc membrane
staining to an endothelial cell line. Previously, rationally
designed constructs to this receptor failed E. coli expres-
sion. This illustrates that this novel genetic selection
method will be useful for discovery of expression
constructs for both structural work and monoclonal
antibody production for functional studies.
METHODS
Materials
Oligonucleotides were synthesized by Sigma-Genosys
(Haverhill, UK). Restriction enzymes and Endonuclease
V were from New England Biolabs (Hitchin, UK). The
vectors pENTR1A, pDEST17 and Gateway LR clonase
were from Invitrogen (Paisley, UK). Plasmid, gel extrac-
tion and PCR puriﬁcation kits were purchased from
Qiagen (Crawley, UK). All other chemicals including
antibiotics unless stated were from Sigma-Aldrich
(Gillingham, UK).
Preparation of uracil containing templates, Endonuclease V
digestionanddAtailingofrandomfragmentedDNAlibraries
The uracil-containing Fli1 and Pecam1 genes were
prepared with PCR mixtures, which contained 10mM
Tris–HCl (pH 8.0), 50mM KCl, 1.5mM MgCl2 and
0.2mM each of dATP, dGTP, dCTP and 0.2mM of
dTTP/dUTP mixture, 0.25mM of each forward and
reverse primers, 10ng of each template plasmid and
1.25U of Taq polymerase (Sigma-Aldrich) in a ﬁnal
volume of 50ml. PCR reaction conditions were: 958C for
2min, followed by 30 cycles of 948C for 30s, 548C for 30s,
and extension at 728C for 3.5min for Fli1 and 5min for
Pecam1 and a ﬁnal extension at 728C for 7min. Ampliﬁed
DNA was puriﬁed using a PCR puriﬁcation column
(Qiagen) and eluted with 50ml of ultra-pure water. These
samples were diluted in 2  Endonuclease V digestion
buﬀer [20mM HEPES–KOH (pH 7.4), 100mM NaCl,
1mM MnCl2]. Two units of Endonuclease V were added
to the diluted DNA sample (3mg) and incubated at 378C
for 12h followed by 958C for 10min. Digested fragments
were puriﬁed using PCR puriﬁcation columns and eluted
in 50ml of 10mM TE (pH 8.0) for subsequent reactions.
Smaller fragments (<100bp) were removed using
microspin 400 columns (GE Healthcare, Little Chalfont,
UK) according to the manufacturer’s instructions and
then concentrated using microcon centrifugal ﬁlter devices
(Millipore, Watford, UK). One microgram of fragmented
DNA was blunt-ended in a reaction containing 50mM
Tris–HCl (pH 8.0), 5mM MgCl2, 0.1mg/ml nuclease-free
BSA, 0.2mM dNTP mix, 1mM DTT and 1.5 units of T4
DNA polymerase (NEB) in a total volume of 25ml and
incubated at 118C for 20min followed by 758C for 10min.
Following the ﬂushing reaction, the entire mixture was
used in the dA tailing step. A total of 8.5mlo f1 0   dA
tailing buﬀer (100mM Tris–HCl, pH 9.0, 0.5M KCl, 0.1%
gelatin, 1% Triton X-100), 0.5ml (1.25U) of Tth poly-
merase (Novagen, Nottingham, UK) was added in a ﬁnal
volume of 85ml and incubated at 708C for 15min. The dA-
tailed samples were puriﬁed using PCR puriﬁcation spin
columns and eluted in 30ml of 10mM TE (pH 8.0),
digested with 5U of Dpn1 enzyme at 378C for 4h, to
remove methylated plasmid DNA and puriﬁed by PCR
puriﬁcation spin columns to give a ﬁnal insert concentra-
tions of between 15 and 20ng/ml.
Construction of entry andexpression vectors
The T-vector was constructed by digestion of pENTR1A
with DraI and EcoRV, agarose gel puriﬁcation and the dT
tailing carried out as previously described (5). The
pDEST17-MCS was constructed by whole plasmid PCR
as described previously (1) using forward primer 50 CAT
ATGGGTACCTAATGAGTTTGATCCGGCTGCTAA
CAAAGCCCGAAAGGAAG 30, reverse primer 50 ATG
CATCACTTCGTGCACCACTTTGTACAAGAAAGC
TGAACG 30 and template pDEST17 to insert a DraIII
site downstream of the attR2 sequence. The pRLP101 was
constructed by ligation of the 1791bp fragment, generated
by XbaI/DraIII digestion of pDEST17-MCS, with the
6190bp XbaI/DraIII vector back-bone from pDEST-
C102 (1).
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T-tailed entry plasmid (50ng) was ligated with the dA
tailed insert (40ng) at a 1:3 molar ratio (6), puriﬁed using
PCR puriﬁcation spin columns and 1ml used to electro-
porate 20mlo fE. coli DH5a-E electrocompetent cells
(Invitrogen). Four electroporations were carried out
for each fragmented gene library and plated onto LB
kanamycin (100mg/ml) plates. The colonies from plates
were scraped, resuspended in 20ml LB media and a total
of 10 OD600 units spun down and miniprep plasmid
DNA prepared (Qiagen). Puriﬁed DNA was used in LR
Gateway recombinations (1) with pRLP101 expression
vector. The reactions were puriﬁed by PCR spin column,
eluted with 30ml of ultra-pure water and 1ml of the eluate
was used to transform E.coli DH5a-E electrocompetent
cells as described earlier. Two electroporations were
carried out for each gene library and the average library
size was 1 10
6. DNA was puriﬁed as described earlier
and 1ml of miniprep DNA was used to transform E. coli
Ultra BL21(DE3) cells (Edge BioSystems, Gaithersburg,
USA). Transformations were plated onto minimal media
agar plates (1  M9 salt, 0.002% glucose, 1mM MgSO4
and 100mg/ml ampicillin). Plates used in selection
contained 75mg/ml TMP and 100mM IPTG in addition
to the above described recipe. All the plates were
incubated at 308C for either 18h (non-selective) or 36h
(selective+TMP+IPTG).
Expression screening
Colonies were picked and inoculated into 500ml of non-
inducing P0.5G minimal media (7) in a 96 deep well block
and these were shaken at 800r.p.m. (3mm orbital throw)
overnight at 378C. The overnight cultures (1.25ml) were
used to inoculate 1.25ml of ZYP-5052 auto-induction
media (7) in a 96 deep well block, which was grown at
378C, shaken at 800r.p.m. for 4h followed by 208C for
18h. Total and soluble protein analysis was essentially as
described previously (1) except that solubility screening
ﬁlter plates (Novagen) were employed.
Ligation-independent cloning and proteinexpression
with
15N labelling
Selected fragments from Fli1 and Pecam1 were PCR
ampliﬁed with primers containing forward linker
50 GGCGGTGGTGGCGGCATG 30 and reverse linker
50 CAGTTCTTCTCCTTTGCGCCCCTA 30 to clone into
to pLIC.B3 [gift from Rosalind Kim, Lawrence Berkeley
National Laboratory, USA (8)]. Ligation independent
cloning was carried out as previously described (http://
www.strgen.org/protocols/). The resultant constructs with
N-terminal hexahistidine tags were expressed at the 2l
scale in P-5052 media (7) for
15N isotope incorporation.
Protein purification, analyticalsize exclusion
chromatography and nuclear magnetic resonance (NMR)
Puriﬁcation of His-tagged protein fragments and size
exclusion chromatography were performed as detailed in
the Supplementary Methods section.
1H and
1H-
15N
HSQC NMR data were collected at 258C on a Bruker
DRX 500 spectrometer equipped with 5mm triple
resonance H/C/N/z-gradient probe on
15N labelled 50
and 100mM samples in 20mM Na phosphate buﬀer
(pH 6.0), 300mM NaCl, 10% D2O. A spin-echo sequence
was used to collect
1H spectra and a
15N HSQC with water
ﬂip-back and a Watergate sequence was used to collect the
2D spectra. Spectra were processed with Azara software
(written by Wayne Boucher, University of Cambridge)
and analysed with relevant tools.
Generationof single chain variable fragments (ScFv)
andimmunocytochemistry
ScFv were selected by antibody phage display panning,
expressed and puriﬁed as previously described (9–11).
Hemangioendothelioma (EOMA) endothelial cell line
was grown in chamber slides until 70% conﬂuent and
ﬁxed with 1% paraformaldehyde (see Supplementary
Methods). The slides were incubated with ScFv at
5mg/ml concentration overnight, washed, followed
by the addition anti-FLAG biotin antibody (2.5mg/ml)
and streptavidin-peroxidase (Molecular Probes, Glasgow,
UK). Slides were then incubated in tyramide-AF647
followed by 40,6-diamidino-2-phenylindole (DAPI)
(Molecular Probes). Slides were mounted with Prolong
gold antifade mountant (Molecular Probes) and dried
overnight before viewing under the microscope. Slides
were viewed using Olympus BX51 microscope, with an
EXFO X-cite 120 ﬂuorescence illuminator. Images were
capture at 20  objective under a plain ﬁeld lenses and
Olympus F-view II cooled black & white camera. Cell B
imagine software was used to create composite images.
RESULTS
mDHFR acts as aproteinsolubility reporter
To test if mDHFR could be used as a genetic selection
reporter of soluble protein expression, a number of E. coli
BL21(DE3) expression clones were streaked onto minimal
plates containing ampicillin and IPTG in the presence or
absence of TMP. TMP is a potent inhibitor of bacterial
DHFR, but does not eﬀectively inhibit murine or human
DHFR. Therefore, only bacteria expressing TMP resistant
(TMP
R) mammalian DHFR will enable growth in the
presence of TMP. The strains hosted the expression
plasmid pDEST-C102-Dhfr, described previously (1),
designed to express cloned open reading frames (ORFs)
with a C-terminal mDHFR fusion protein. The clones
expressed the tyrosine kinase or SAM domain of the
murine EphB2 receptor (EphB2-TK or EphB2-SAM,
respectively), the murine transcription factor Fos and
Aequorea victoria green ﬂuorescent protein (GFP) mutant
(4) engineered for soluble expression in E. coli (12). As
shown in Figure 1A, all bacterial strains grew well when
streaked onto expression plates in the absence of TMP,
but in the presence of TMP only the strains expressing the
known soluble proteins EphB2-SAM and GFP (1) grew
well (plate segments 2 and 4), whereas the insoluble
proteins EphB2-TK and Fos either failed to grow or grew
very slowly after a 30h incubation at 30
8C (plate segments
PAGE 3 OF 12 Nucleic Acids Research, 2008, Vol. 36, No. 9 e511 and 3, Figure 1). The growth results illustrated in
Figure 1A provide evidence that mDHFR can act as a
dominant genetic reporter of soluble protein expression.
Upstream protein fusions to DHFR that are prone to
misfolding and inclusion body formation can perturb the
folding and therefore enzymatic activity of DHFR.
Additional evidence for the ability of DHFR to act as a
solubility reporter came from liquid culture experiments in
minimal media containing IPTG and ampicillin, where the
growth rates of strains expressing the soluble EphB2-SAM
and GFP or insoluble EphB2-TK or ketosteroid isomerase
(KSI) were compared in the absence or presence of TMP.
As shown in Figure 1B, all expression strains grew equally
well in the absence of TMP, but in the presence of TMP
(Figure 1C) the strains expressing low or undetectable
levels of soluble protein (Figure 1D) displayed markedly
reduced growth kinetics.
Construction of fragmentedlibraries
The DHFR reporter vector pRLP101 (Figure 2) is
essentially the same as the previously described expression
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Figure 1. Murine dihydrofolate reductase (mDHFR) can act as a protein solubility reporter. (A) Escherichia coli BL21(DE3) expressing mDHFR
fused to tyrosine kinase (1) or SAM domain (2) of the murine EphB2 receptor, c-Fos (3) or GFP (4) were streaked onto minimal agar plates
containing ampicillin and IPTG in the presence (+) or absence ( ) of trimethoprim. (B) and (C) Growth rate studies of E. coli BL21(DE3)
expressing various N-termimal fusion proteins to mDHFR in the absence (B) or presence (C) of trimethoprim. (D) SDS–PAGE western blots
for total (T) and soluble (S) expression of EphB2-SAM, GFP, EphB2-TK and KSI expressed as mDHFR fusions. Marker lane (m)=His-tag ladder
(Qiagen).
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Dalgarno sequence and start codon were inserted down-
stream of the lac operator (lacO). The presence of the lacO
and plasmid encoded lac repressor (lacI) was found to be
important in the selection experiments to reduce the eﬀects
of protein over-expression toxicity caused by high rates
of transcript synthesis (data not shown). GATEWAY
vectors were used because they allow the ﬂexibility of
shuﬄing inserts between multiple expression vectors and
reporter systems without the need to use PCR ampliﬁca-
tion or restriction enzyme cloning (13,14).
We adapted the method of Miyazaki (4), originally used
for random DNA fragment generation prior to DNA
shuﬄing mutagenesis, for creation of a library of gene
fragments to be used for protein solubility selections. The
proto-oncogene Fli1 (Friend leukemia integration 1 trans-
cription factor, UNIPROT accession P26323) was chosen
as the initial target because previous studies showed that
even when expressed with the N-terminal solubility
enhancing fusions maltose binding-protein (MBP) and
thioredoxin (Trx), extensive proteolytic cleavage of the
full-length product occurred (1) resulting in very poor
yields during attempted puriﬁcation. The Fli1 ORF was
ampliﬁed with gene-speciﬁc primers in the presence of
diﬀerent ratios of dTTP and dUTP and the product was
digested with E. coli Endonuclease V, a repair enzyme that
recognizes deoxyinosine and deoxyuridine and cleaves at
the second and third phosphodiester bonds 30 to the
mismatch with a 95% eﬃciency for the second bond and
a 5% eﬃciency for the third bond leaving a nick with
30-hydroxyl and 50-phosphate (15). Endonuclease V cleav-
age in the presence of manganese (II) promotes double
strand cleavage (K. Miyazaki, personal communication).
As shown in Figure 3A, Endonuclease V does not cleave
the Fli1 ORF ampliﬁed without dUTP (lane 1), but as the
percentage dUTP employed in the PCR increased
progressively greater fragmentation occurred (lanes 2–5).
The fragments generated by Endonuclease V cleavage of
PCR product ampliﬁed with 50% and 75% dUTP (lanes 3
and 4) were end repaired with T4 DNA polymerase and
50 A-tailed with Tth polymerase. The inserts were cloned
into the T-tailed DraI/EcoRV cut pENTR1A vector (see
Materials and methods section) to give a total library size
of 9.8 10
5. To check library diversity 240 clones were
picked and DNA sequenced. A size distribution was
achieved in the range from 0 to 800bp (Figure 3B) centred
at 100–200bp. The sequences of the non-redundant Fli1
inserts were aligned to the full-length reference sequence
and ordered from their 50-end (Figure 3C) or 30-end
(Figure 3D), to check library diversity. Inserts in frame at
the 50 and 30-ends and the correct orientation are coloured
red. Steps in the fragment distribution were observed
indicating some Endonuclease V cleavage ‘hot-spots’, such
as the 30 780–792bp region. This sequence was character-
ized by being relatively AT rich (67%) and was ﬂanked by
two 12bp GC-rich regions. Diversity could be increased
by also preparing a deoxyinosine doped PCR product
performing Endonuclease V cleavage and combining
this with the library generated from the deoxyuridine
incorporated PCR product. This was not performed
in this report because the library was considered to have
suﬃcient diversity, with good coverage of the two anno-
tated domains to proceed with selection experiments.
Coverage of the entire gene was achieved and no region of
the gene appeared to dominate the library.
Selection of solubleFli1 fragments
The Fli1 fragment library, cloned into pENTR1A, was
recombined with pRLP101 to give a library of expression
clones. The library was plated onto minimal agar plates
containing ampicillin and IPTG in the presence or absence
of TMP. Comparing the selective (+TMP) with the non-
selective ( TMP) plates there was an average 66-fold
reduction in the number of transformants, indicating that
selection was taking place. Growth on the TMP plates was
dependent on plasmid induced protein expression because
T7 lacO attR1 attR2 H10 stop mDHFR CmR SD H6
A XbaI DraIII
ccdB
B attB1 
|
10           20           30            40           50           60            70      
ATG TCG TAC TAC CAT CAC CAT CAC CAT CAC CTC GAA TCA ACA AGT TTG TAC AAA AAA GCA GGC TTT TNN NNN NAT
M   S   Y   Y   H   H   H   H   H   H   L   E   S   T   S   L   Y   K   K   A   G   F      ORF    
attB2                              DraIII mDHFR
|                                  |           |        
80           90           100       |  110      |   120      130                   
CTA GAC CCA GCT TTC TTG TAC AAA GTG GTG CAC GAA GTG CGA CCA TTG AAC TGC ATC GTC GCC
L   D   P   A   F   L   Y   K   V   V   H   E   V   R   P   L   N   C   I   V   A   
Figure 2. Map of the mDHFR reporter vector. (A) Schematic depiction of pRLP101. T7, T7 RNA polymerase promoter; SD, Shine–Dalgarno; lacO,
lac operator; attR1, attR2, att recombination sites; CmR, chloramphenicol resistance gene; ccdB, bacterial toxin gene (inhibitor of DNA gyrase);
mDHFR, murine dihydrofolate reductase; H6 or H10, hexahistidine or decahistidine; ORF, open reading frame. (B) DNA sequence of the ﬁnal
expression construct (see Materials and methods section). The sequence covers from the start codon to the ﬁrst eight amino acids of mDHFR. The
ORF is cloned at position 68–73bp.
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of IPTG. A total of 64 TMP resistant transformants
were picked into minimal media, expressed using auto-
induction medium [see Materials and methods section (7)],
analysed for soluble protein expression (16) (Figure 4A)
and sequenced (Supplementary Table 1). Thirty percent
(19/64) of the TMP-resistant transformants gave soluble
expression and of those sequence conﬁrmed 75% (12/16)
were cloned in the forward orientation and in frame at
both the 50 and 30 junctions (Supplementary Table 1). The
aligned in frame soluble expression hits (Figure 4B) gave a
striking consensus relative to the random nature of the
initial starting library (Figure 3C and D) homing on the
DNA binding ETS domain. The equivalent human Fli1
ETS domain is the only region of this protein to have been
expressed in E. coli and crystallized (17). The solved
domain consisted of aa276–373 and it is interesting to note
the diﬀerence with the annotated Pfam (3) ETS coordi-
nates at aa280–363, being 14 amino acids smaller than the
structural domain. In this study, the successful selection
illustrates that the method can be used to rapidly identify
folded regions of a larger protein that are capable of
soluble expression at levels that are suﬃcient for structural
determination.
Selection ofsoluble Pecam1 fragments
The method was tested on a larger, more complex protein:
murine platelet endothelial cell adhesion molecule
(Pecam1 or Cd31, Uniprot accession number Q08481).
Pecam1 is a type 1 integral membrane cell adhesion
molecule expressed on platelets and at endothelial cell
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Figure 3. Generation of a library of Fli1 fragments. (A) Full-length Fli1 gene was PCR ampliﬁed in the presence of diﬀerent dTTP/dUTP ratios,
digested with endonuclease V and analysed by agarose gel (1.6%) electrophoresis. Lane M, DNA standard (HyperLadder1;BIOLINE marker); lane
1, 0.2mM dTTP/0mM dUTP; lane 2, 0.15mM dTTP/0.05mM dUTP; lane 3, 0.1mM dTTP/0.1mM dUTP; lane 4, 0.05mM dTTP/0.15mM dUTP;
lane 5, 0mM dTTP/0.2mM dUTP. (B) Histogram showing the size distribution frequency (N) of 240 randomly picked Fli1 library entry plasmids.
(C) Coverage plot of a non-redundant set of 173 sequence conﬁrmed Fli1 entry plasmids arrayed against the 1359bp Fli1 sequence (lower line) with
annotated SAM domain (blue, 343–595bp) and ETS domains (green, 841–1090bp) sorted from their 50 end. Red lines are inserts in frame at the 50
and 30 junctions and the correct orientation. (D) as (C) except the clones are ordered from their 30 end.
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generated in pENTR1A, as for Fli1, cloned into pRLP101
and 96 TMP-resistant transformants were picked,
screened for soluble expression and DNA sequenced
(Supplementary Table 2). Twenty-eight percent (27/96)
of the TMP-resistant clones gave soluble protein expres-
sion and of those DNA sequenced 65% (17/26) were in the
correct orientation and in frame at the 50 and 30 junctions.
The soluble protein expression hits covered several
extracellular regions of the protein including all the
individual Ig domains and one was located in the
intracellular cytoplasmic tail region (#84, Figure 5).
Biophysical characterization ofthe solubleFli1 and
Pecam1 fragments
To test if the regions of Fli1 and Pecam1 identiﬁed from
the mDHFR screen were correctly folded in the absence of
the mDHFR fusion, selected constructs were sub-cloned
into a His tag expression vector, expressed and aﬃnity
puriﬁed. Fli1 clone #12 was chosen as this was the
smallest selected fragment (266–383/452aa) covering the
annotated Pfam ETS domain (280–363aa). Fli1 clone #10
(247–386aa) was selected as an example of a larger
fragment containing the ETS domain with good levels of
soluble expression (Figure 4A). Pecam1 clones #26, #71,
#57, #74 and #84 were picked for further characteriza-
tion because these covered all the individual SMART
annotated extracellular Ig and Ig-like domains and
the intracellular domain. Expression in 50ml of auto-
induction media (7) and aﬃnity puriﬁcation was successful
for the Fli1 clones and Pecam1 intracellular clone #84, but
the selected Pecam1 extracellular domains failed to give
suﬃcient material for biophysical characterization.
Filtration or centrifugation is commonly used to
separate the soluble protein fraction from inclusion
bodies, but this soluble fraction can contain aggregates
which may not be natively folded (18,19). For this reason,
size exclusion chromatography (SEC) was used to
determine the aggregation state of the His-tagged Fli1
and Pecam1 fragments. Table 1 shows the expected
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Figure 4. Selection of soluble fragments of Fli1. (A) Western blot results for total (T) and soluble (S) expression of all 64 Fli1 expression clones after
selection for growth on trimethoprim plates. (B) Schematic diagram for soluble Fli1 hits aligned to the reference sequence with annotated SAM
(blue) and ETS (green) SMART (45) domains. The coordinates of the expression clones are contained in Supplementary Table 1. Clone numbers
correspond between Figure 4A and B, Supplementary Table 1.
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the SEC calibration curves and the inferred aggregation
state. Fli1 constructs 10 and 12 (Table 1) covering the ETS
domain with diﬀerent ﬂanking lengths gave calculated
molecular weights consistent with them having a mono-
meric state, although the shorter fragment 12 gave the best
agreement between the experimentally determined and
theoretical molecular weights. The Pecam1 fragment most
closely approximated to an apparent trimeric state.
Fli1 fragment 12 containing the DNA binding ETS
domain and Pecam1 fragment 84 covering the receptor
cytoplasmic domain were expressed at a 2l scale in
minimal auto-induction media for
15N labelling of pro-
teins [see Materials and methods section (7)] and puriﬁed
by aﬃnity, ion-exchange and SEC to give puriﬁed yields of
0.5 and 3.0mg of labelled protein, respectively for NMR
studies.
The proteins were ﬁrst analysed by 1D
1H NMR.
Methyl group proton chemical shift signals in the region
of 1.0 to  1.0p.p.m. disperse when a methyl group is
placed in the core of the protein and can be indicative of
correct protein folding (20,21). The Fli1 fragment clearly
shows some well-dispersed peaks in the region of 1 to
 1p.p.m. (Figure 6A), whereas the Pecam1 fragment does
not (Figure 6B).
1H-
15N HSQC (Heteronuclear Single
Quantum Coherence) NMR spectra (21,22) showed well
dispersed and sharp resonances for the Fli1 construct
(Figure 6C), but this was not apparent for the Pecam1
cytoplasmic domain (Figure 6D). The most intense and
sharp signals in the centre of the Fli1 HSQC spectrum
belongs to the disordered His-tag. All of the resonances in
the spectrum of Pecam1, a domain of similar size, are at
least as sharp, indicating a disordered and well soluble
protein. Pecam1 does not form larger aggregates, which
would markedly widen the resonances. Taken together,
the 1D NMR and 2D NMR data are consistent with the
monomeric Fli1 12 construct being folded, whereas the
Pecam1 84 fragment is disordered rather than trimeric, as
indicated by size exclusion. Disordered proteins are
known to occupy a larger volume than compact globular
proteins under native conditions.
Utility of selected fragments inantibody generation
Although the Pecam1 cytoplasmic domain construct #84
was judged to be unfolded by the NMR screens, we were
interested to investigate if this soluble, disordered protein
could be used to produce speciﬁc antibodies capable of
recognizing the full-length Pecam1 cell surface receptor
in cultured cells. The his-tagged construct was used to
generate speciﬁc single chain (scFv) antibodies by anti-
body phage display selection (10). ScFv were sub-cloned
into pSANG14-3F, which expresses scFv–alkaline phos-
phatase fusions (9), and expressed in auto-induction media
(7). These were aﬃnity puriﬁed and ranked for binding to
Pecam1 #84 as described previously (11). From a panel of
96 selected scFv clones, 36 possessed unique DNA
sequences (11) and speciﬁcally recognized Pecam1 #84
indicating that the selection was successful. The antibody
clone and ELISA speciﬁcity data are available via the
AtlasDB (11) web-site (http://www.sanger.ac.uk/cgi-bin/
teams/team86/AtlasDB.pl). Clones ant699_808_B04 and
ant699_808_G08 were chosen for immunocytochemistry
(ICC) analysis because they gave the highest ELISA
signals for binding to the puriﬁed His-tagged Pecam1
intracellular #84 protein. A scFv (ant65_d05) speciﬁc
for the receptor Jagged-1 (11) was used as a positive
control as a known marker that is co-expressed on
endothelial cells with Pecam1 (23). The anti-Jagged-1
scFv, and anti-Pecam1 scFv clones ant699_808_B04 and
ant699_808_G08 all gave a characteristic membrane
staining pattern when incubated with ﬁxed mouse
EOMA cells (Figure 7A–C, respectively) and detected
via the FLAG tag (see Materials and methods section).
A scFv speciﬁc to Rab9b (ant308_180_G02), which is
expressed speciﬁcally in brain and spinal cord (http://
cgap.nci.nih.gov/SAGE) was included as a negative
control and this gave no staining of the EOMA cells
(Figure 7D).
DISCUSSION
This work combines an eﬃcient method of DNA
fragmentation with a genetic screen, employing a
C-terminal mDHFR fusion, for the identiﬁcation of
protein constructs capable of soluble expression in
E. coli. Production of a pool of random DNA fragments
by Endonuclease V has some advantages over the
alternate methods (24). The physical methods of sonica-
tion (14) or shearing (25) produce the most random
libraries due to their lack of dependence on sequence, but
DNA damage can occur, perhaps due to free radical
generation during cavitation (26). DNAse (27) or exonu-
clease digestion (28–30) requires that the reaction condi-
tions must be determined empirically on a gene by gene
basis. Also, the exonuclease methods may not allow
sampling of all the available internal sequence space when
making successive N- or C-terminal deletions. Random
PCR (31,32) can result in biases in the preferential
ampliﬁcation of GC-rich regions resulting in a non-
random library. PCR with a dTTP/dUTP mix (33)
followed by ﬁrst uracil-DNA glycosylase addition and
next cleavage at the resulting abasic sites with Endonu-
clease IV has the advantage that no enzyme titrations
or time courses are required. Cleavage is driven to
completion with the insert size library being solely
bp
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Figure 5. Schematic diagram for soluble Pecam1 hits aligned to the
reference sequence with annotated Ig (blue) and Ig-like (green) SMART
(45) domains, signal sequence (brown) and transmembrane domain
(red). The coordinates of the expression clones are contained in
Supplementary Table 2.
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original insert PCR. The fragmentation method described
in this report is similar to the method of Reich et al. (33),
but in this method cleavage is eﬀected in a single
enzyme step.
We describe mDHFR as a new genetic reporter of
soluble expression and provided evidence to support this
with some known soluble and insoluble proteins. The
principle of this technique is that only soluble N-terminal
fusions allow the correct folding of the downstream
reporter protein, whereas misfolded N-terminal fusions
perturb the folding and therefore activity of mDHFR.
Alternate reporters of soluble protein expression can be
separated into those that lead to a colour (34) or
ﬂuorescence (12,35,36) read-out allowing one to pick
transformants displaying the correct phenotype, and those
that act as dominant genetic markers (37–39) where, in
the presence of an appropriate antibiotic, a growth advan-
tage is conferred on clones that express soluble protein.
A non-fusion reporter system has been used where
b-galactosidase was cloned downstream of the chromoso-
mal ibpAB promoter, which is upregulated in response
to an accumulation of unfolded protein (40). However,
larger library sizes can be screened more rapidly with the
dominant genetic markers (41). This is particularly useful
for random insert cloning where there is a 1 in 18 chance
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Figure 6. Biophysical analysis of selected soluble domains. 1D proton NMR spectra of Fli1 10 (A) fragment and Pecam1 84 fragment. (B)2 D
15N-HSQC spectra results of Fli1 10 (C) fragment and Pecam1 84 fragment (D).
Table 1. Apparent aggregation state of selected Fli1 and Pecam1 protein fragments
Gene Construct Fragment (aa) Ve (ml) KAV MWcalc (kDa) MWtheor (kDa) Mwcalc/MWtheor
Fli1 10 247–386 1.29 0.304 24.9 17.3 1.44
Fli1 12 266–383 1.39 0.366 15.5 14.8 1.05
Pecam1 44 631–727 1.19 0.242 39.9 14.3 2.79
Comparison of calculated molecular weights (MWcalc) from SEC data and theoretical molecular weights (MWtheor) of His-tagged proteins.
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at both the 50 and 30 junctions meaning that larger libraries
must be sampled to screen suﬃcient correctly cloned
inserts for soluble expression. Chloramphenicol acetyl
transferase has been used as a genetic marker (38), but
this is active as a trimeric protein and may lead to higher
order aggregate protein fusions. Selection based on
protein secretion to the bacterial periplasm and fusion to
b-lactamase (BlaC) is a very promising system (37),
although one needs to be careful to eliminate false positive
clones that occur through passive BlaC leakage from cells
and secretion is limited to proteins of less than 90kDa in
molecular mass. Recently, over-expression of E. coli
DHFR has been used as a reporter of soluble protein
expression, but this is a highly soluble protein and may
increase the solubility of the upstream fusion, although the
authors were successful selecting for mutants of an
acetyltransferase (39) with improved properties. The
advantage of mDHFR as a genetic reporter is that it is
monomeric and has been shown previously (1) not to
signiﬁcantly perturb the folding of N-terminal fusion
proteins. Also, DHFR is not a common plasmid marker
in E. coli unlike b-lactamase, chloramphenicol acetyl
transferase or kanamycin resistance making it compatible
with a wider range of bacterial expression systems.
The method was validated using the transcription factor
Fli1, which cannot be expressed as a full length protein in
E. coli (1). From a pool of random DNA fragments,
mDHFR selection successfully identiﬁed soluble expres-
sion clones of the ETS domain of murine Fli1, judged
to be folded by 1D and 2D NMR. Indeed, this was the
only region of the human orthologue to have its structure
solved (17). Some false positive TMP
R clones were
identiﬁed which did not express soluble protein as
judged by a ﬁlter plate screen (16). The reason for this
could be that initial expression of these constructs as
DHFR fusions resulted in soluble expression allowing
growth on TMP plates, but as the levels of over-expressed
proteins increased in the cell during induction, this gave
rise to inclusion body formation. Alternatively, low levels
of proteolysis between the fusion protein and mDHFR
may release suﬃcient soluble and active mDHFR to allow
growth on TMP plates despite the misfolding and
aggregation of the full-length fusion protein. Also, some
reverse orientation insertions were observed and here it is
likely that internal initiation from an upstream in frame
AB
CD
Figure 7. ScFv giving membrane staining to the EOMA endothelial cell-line. Immunocytochemistry results for single chain Fv (in red) raised against
Jagged-1 (A), Pecam1 #84 fragment, clone ant699_808_B04 (B) or clone ant699_808_G08 (C) and Rab9B. (D) Nuclei were stained with DAPI (blue)
as described in Materials and methods section.
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false positive rate by mutating mDHFR to make it more
sensitive to misfolding of an N-terminal fusion partner.
However, despite the occurrence of these false positive
TMP
R clones, suﬃcient enrichment of soluble expression
clones occurred to be useful in subsequent studies.
A comparison between the Fli1 and Pecam1 selection
results indicates that the success rate of this selection
method is likely to be target speciﬁc and might favour
proteins normally expressed in the nucleus or cytoplasm
compared with extracellular proteins. Several soluble
expression fragments of the more complex target platelet
endothelial cell adhesion molecule (Pecam1) were identi-
ﬁed. When expressed as His-tagged proteins, only the
cytoplasmic domain construct was capable of high levels
of soluble expression. This may reﬂect the diﬃculty
of expressing ectodomains of mammalian cell surface
receptors, which are naturally glycosylated and contain
disulphide bonds in vivo and may require a mammalian
expression system (42) or expression with speciﬁc fusion
partners and E. coli strains (43) with co-expression of
chaperones for optimal expression. The possibility of false
negative clones cannot be ruled out for slow-folding
fusions. If a fragment is still in the process of folding when
the mDHFR polypeptide emerges from the translating
ribosome, this could interfere with the folding of the
reporter. The observation that the Pecam1 extracellular
fragments appeared soluble in the ﬁlter plate screen (16)
but failed attempted puriﬁcation could be that the ﬁlter
plate screen fails to diﬀerentiate between monomeric
or dimeric protein and higher order aggregates, which
appear an soluble inclusion bodies (18). Alternatively, the
proteins were initially expressed correctly folded, but
they aggregated during puriﬁcation, perhaps due to their
lack of hydrophilic glycosylation. The Pecam1 selection
illustrates that rigorous validation of TMP
R expression
clones should be performed including solubility screening
and puriﬁcation. The Pecam1 extracellular selected frag-
ments could be useful for suggesting constructs to be
tested in alternate prokaryotic (43) or eukaryotic expres-
sion systems assuming that they were initially expressed
solubly, but aggregated over time due to not being in the
correct environment.
It was previously found that some mammalian proteins
expressed in E. coli as MBP fusions failed to work in
phage—antibody display selections (11). They may have
been prone to soluble inclusion body formation, which
could have sterically hindered the antigen’s accessibility
for single chain antibody selection. The selected Pecam1
fragment was shown not to be a soluble higher order
aggregate, but most likely as a disordered monomeric
species, as judged from the NMR data, and did not
require to be expressed as a MBP fusion for high level
soluble expression. The selected cytoplasmic domain of
Pecam1 is likely to be an example of a protein existing in
a natively unfolded state (44) because this region is
phosphorylated and during receptor signalling recruits the
protein-tyrosine phosphatases SHP-1 and SHP-2 (39) and
therefore requires ﬂexibility for function. The selected
Pecam1 cytoplasmic domain consisted of 631–727aa,
whereas a rationally designed construct to express the
cytoplasmic domain of the receptor, consisting of
620–727aa could only be expressed as a MBP fusion and
this failed antibody phage display selection [see Schoﬁeld
et al. (11), ant238]; presumably, because it gave rise to
soluble inclusion bodies. This illustrates the power of
screening versus design where a diﬀerence of a few amino
acids can make the diﬀerence between success and failure.
CONCLUSIONS
We provide a method combining random DNA fragmen-
tation by Endonuclease V together with genetic selection
using mDHFR for the identiﬁcation of protein fragments
capable of soluble expression in E. coli. This is the ﬁrst
study to combine random fragmentation with genetic
selection to identify soluble protein expression constructs.
The methods will be particularly useful in cases where the
attempted expression of the full-length protein has failed
or where there is insuﬃcient domain annotation for
rational design.
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Supplementary Data are available at NAR Online.
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